ConductScience.org, home

Paper7627993

Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies.

Ragnhammar P and 5 others. Cancer Immunol Immunother, 1995. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies. Papers, record 7627993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7627993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2024-04-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ragnhammar PP
2Fagerberg JJ
3Frödin JEJ E
4Wersäll PP
5Hansson LOL O
6Mellstedt HH

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Anti-IdiotypicMajor topic
Antibodies, MonoclonalMajor topic
Antibodies, NeoplasmMajor topic
Colorectal NeoplasmsMajor topic
Granulocyte-Macrophage Colony-Stimulating FactorMajor topic
ImmunotherapyMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Immunoglobulin Isotypes
Immunotoxins
Male
Middle Aged

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11373150Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody.J Clin Immunol1992https://conductscience.org/library/papers/1373150PubMed
23488949Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma.Hybridoma1986https://conductscience.org/library/papers/3488949PubMed
37934495Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.Lancet1994https://conductscience.org/library/papers/7934495PubMed
4286328Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/286328PubMed
54126980Speculations on idiotypes and homobodies.Ann Immunol (Paris)1973https://conductscience.org/library/papers/4126980PubMed
63488950Phase I clinical trial of CO17-1A monoclonal antibody.Hybridoma1986https://conductscience.org/library/papers/3488950PubMed
76582477Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6582477PubMed
83874237Human immune response to multiple injections of murine monoclonal IgG.J Immunol1985https://conductscience.org/library/papers/3874237PubMed
91937495
Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?
Hybridoma1991https://conductscience.org/library/papers/1937495PubMed
107909866Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.Lancet1994https://conductscience.org/library/papers/7909866PubMed
112787530Monoclonal antibody-mediated tumor regression by induction of apoptosis.Science1989https://conductscience.org/library/papers/2787530PubMed
128124683
Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?
Cancer Immunol Immunother1994https://conductscience.org/library/papers/8124683PubMed
134142565Towards a network theory of the immune system.Ann Immunol (Paris)1974https://conductscience.org/library/papers/4142565PubMed
142726771Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2726771PubMed
152649128Monoclonal antibodies for imaging and therapy.Br J Cancer1989https://conductscience.org/library/papers/2649128PubMed
163744377Trial of therapy with monoclonal antibody 17-1A in pancreatic carcinoma: preliminary results.Hybridoma1986https://conductscience.org/library/papers/3744377PubMed
176587365Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6587365PubMed
181925633The therapeutic use of monoclonal antibodies in colorectal carcinoma.Semin Oncol1991https://conductscience.org/library/papers/1925633PubMed
193744381Chimeric antibodies with 17-1A-derived variable and human constant regions.Hybridoma1986https://conductscience.org/library/papers/3744381PubMed
203878375Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibody.J Immunol Methods1985https://conductscience.org/library/papers/3878375PubMed

See all 34 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
17325709EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges.Br J Cancer2007https://conductscience.org/library/papers/17325709PubMed
9806108Edrecolomab (monoclonal antibody 17-1A).Drugs1998https://conductscience.org/library/papers/9806108PubMed
9514045Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.Br J Cancer1998https://conductscience.org/library/papers/9514045PubMed
8908703Monoclonal antibodies in cancer therapy.Springer Semin Immunopathol1996https://conductscience.org/library/papers/8908703PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7627993

GET https://conductscience.org/api/papers/v1/7627993/references?page=2